Abstract-In ambulatory blood pressure (BP) monitoring, nighttime BP has a superior ability to predict hypertensive target organ damage than awake BP. We evaluated whether nighttime BP, assessed by a home BP monitor, was associated with hypertensive target organ damage. We measured clinic BP, out-of-clinic BP including nighttime home BP, and the urinary albumin:creatinine ratio (UACR) in 854 patients who had cardiovascular risk factors. Nighttime home BP was measured at 2:00, 3:00, and 4:00 AM, in addition to clinic, awake ambulatory, nighttime ambulatory, and awake home BP. Nighttime home systolic BP (SBP) was slightly higher than nighttime ambulatory SBP (difference, 2.6 mmHg; PϽ0.001). Clinic (rϭ0.186), awake ambulatory (rϭ0.173), nighttime ambulatory (rϭ0.194), awake home (rϭ0.298), and nighttime home (rϭ0.311) SBPs were all associated with log-transformed UACR (all PϽ0.001). The correlation coefficient for the relationship between nighttime home SBP and log-transformed UACR was significantly greater than that for the relationship between nighttime ambulatory SBP and log-transformed UACR (PϽ0.001). The goodness of fit of the association between SBP and UACR was improved by adding nighttime home SBP to the other SBPs (PϽ0.001). Nighttime home diastolic BP also improved the goodness-of-fit of the association between diastolic BP and UACR (Pϭ0.001). Similar findings were observed for the left ventricular mass index in the subgroup (Nϭ594). In conclusion, nighttime home BP is slightly different from (but comparable to) nighttime ambulatory BP. The addition of nighttime home BP to other BP measures improves the association of BP with hypertensive target organ damage. (Hypertension. 2012;60:00-00.) • Online Data Supplement Key Words: nighttime home blood pressure Ⅲ home blood pressure Ⅲ awake ambulatory blood pressure Ⅲ nighttime ambulatory blood pressure Ⅲ clinic blood pressure Ⅲ hypertensive target organ damage Ⅲ urinary albumin:creatinine ratio I t has been reported that ambulatory blood pressure (BP) is a superior predictor of future cardiovascular events than clinic BP. [1] [2][3] [4] [5] [6] [7] [8] [9] In particular, nighttime BP measured using an ambulatory BP monitor was shown to be a superior predictor of future cardiovascular events than awake BP.
I
t has been reported that ambulatory blood pressure (BP) is a superior predictor of future cardiovascular events than clinic BP. [1] [2] [3] [4] [5] [6] [7] [8] [9] In particular, nighttime BP measured using an ambulatory BP monitor was shown to be a superior predictor of future cardiovascular events than awake BP. 1, 4, 6 Out-ofclinic BP was originally measured using ambulatory BP monitors; however, it can be measured using home BP monitors. Home BP monitors are cheaper and less cumbersome than ambulatory BP devices; therefore, home BP measurement is widely recommended for the management of hypertension. 10 Home BP is also a better predictor of future cardiovascular events than clinic BP. 6, 8, [11] [12] [13] It used to be difficult to measure nighttime BP using home BP monitors; however, Hosohata et al 14 developed a home BP device that allows nighttime BP readings to be taken at a fixed time (HEM-747IC-N, Omron Healthcare Co, Ltd, Kyoto, Japan). 14 We subsequently developed a nighttime home BP measurement algorithm for taking 3 home BP readings at 1-hour intervals using a cuff-oscillometric device (HEM-5001, Omron Healthcare Co, Ltd). We compared the nighttime BP levels obtained using home and ambulatory BP monitoring and evaluated whether nighttime home BP is associated with hypertensive target organ damage, as was found for nighttime ambulatory BP.
factors, hypertension, impaired glucose tolerance or diabetes mellitus, dyslipidemia, being a smoker (and/or having chronic obstructive pulmonary disease), chronic renal disease, atrial fibrillation, metabolic syndrome, and sleep apnea syndrome. The exclusion criteria for the J-HOP Study were a recent history of cardiovascular or cerebrovascular events (within 6 months), current hemodialysis treatment, chronic inflammatory disease, or malignancy. The study subjects were enrolled between January 2005 and June 2010 by physicians. If the subjects were taking antihypertensive medication, they had to have been receiving stable antihypertensive treatment for 3 months. The institutional review board of Jichi Medical University School of Medicine approved the current study, and written informed consent was obtained from all of the participants of the J-HOP Study. The definitions of cardiovascular risk factors are shown in the online-only Data Supplement (http://hyper.ahajournals.org). Measurements of nighttime home BP and ambulatory BP were obtained as part of an optional substudy, mostly at Jichi Medical University and the related hospitals.
BP Measurements

Clinic BP
Clinic BP was measured by physicians or nurses using an upper arm cuff oscillometric BP device (HEM-5001; Omron Healthcare, Co, Ltd). The Omron HEM-5001 home BP device uses the same BP measurement algorithm as is used by the HEM-737 home BP device, which was validated in a previous study. 15 Three clinic BP readings were taken at 15-second intervals 16 in a sitting position after 2 minutes of rest. The analyses were performed using the mean values of 6 readings obtained during 2 clinic visits (before and after the home BP measurements). We advised the patients to take their morning medication as usual on the days when they were visiting the clinic.
Home BP
Self-measured home BP values were obtained using a validated upper arm cuff oscillometric device (HEM-5001; Omron, Kyoto, Japan). 15 The patients were instructed to place the cuff on the same arm throughout the measurements and to measure their BP in a sitting position after Ն2 minutes of rest according to the Japanese Society of Hypertension 2004 guidelines. 17 Three home BP readings were taken at 15-second intervals in a sitting position in both the morning and evening for 14 days. Morning BP was measured within 1 hour of waking, after urination, before breakfast, and before taking antihypertensive medication. Evening BP was measured before going to bed, and the patients were instructed to avoid measuring their BP just after taking a bath, drinking alcohol, or smoking. The morning and evening BP data were automatically stored in the memory of the BP device and were downloaded to a computer by a physician or nurse during clinic visits. Awake home BP was defined as the mean of the morning and evening BP values obtained at home.
Nighttime Home BP
Hosohata et al 14 previously measured nighttime BP at 2:00 AM on each day of their study using a home BP device. The Omron HEM-5001, the home BP device that we used in this study, is also able to take BP readings at fixed times. We developed an algorithm for measuring nighttime home BP at 1-hour intervals; that is, the home BP device was preset to take nighttime home BP measurements at 2:00, 3:00, and 4 AM (3 points), in consideration of the fact that sleep periods differ among patients. The patients were instructed to wear the cuff and press the button to start the timer when they went to bed and to sleep beyond 4 AM. We instructed the patients to measure their nighttime home BP on as many nights as possible (Ն1 night a week; ie, Ն2 nights during the 14-day study period). The nighttime BP data were automatically stored in the memory of the BP device and were downloaded to a computer by a physician or nurse during clinic visits.
Ambulatory BP
Noninvasive ambulatory BP monitoring was carried out on a weekday with a validated automatic device (TM-2421 or TM-2425; A&D Co Inc, Tokyo, Japan) 18 that recorded the patient's BP using an oscillometric method together with their heart rate every 30 minutes for 24 hours. Nighttime BP was defined as the mean BP for the period from bedtime to rising, and awake BP was defined as the mean BP for the rest of the day. The order of home and ambulatory BP measurements was decided by the patients.
Urinary Samples and Echocardiography
Spot urine samples were collected from all 854 patients included in this study. Urinary albumin was measured using an immunoturbidity kit (AutoWako Microalbumin; Wako Pure Chemical Industries, Osaka, Japan). All of the urinary samples were assessed in a single laboratory (SRL Inc, Tokyo, Japan), and the urinary albumin:creatinine ratio (UACR) was calculated afterward. The echocardiographic measurement method is described in the online-only Data Supplement.
Statistical Analysis
Between January 2005 and June 2010, 4019 consecutive patients were enrolled in the J-HOP Study. In some of these patients, measurements of nighttime home BP and ambulatory BP were also obtained for an optional substudy, which was mostly performed at Jichi Medical University and the related hospitals. The various BP values and the relationships between them were compared, and the UACRs of 854 patients were calculated after excluding patients with incomplete UACR (Nϭ3), clinic BP (Nϭ15), nighttime home BP (Nϭ1329), nighttime ambulatory BP (Nϭ1764), or awake ambulatory BP data (Nϭ1); those with atrial fibrillation (Nϭ52); and a shift worker (Nϭ1). Among the 594 patients for whom echocardiographic data were available, we also evaluated the relationship between BP and left ventricular hypertrophy (ie, the left ventricular mass index [LVMI] and relative wall thickness [RWT]) after excluding the patients who had no echocardiographic data (Nϭ133) or a history of angina pectoris (Nϭ82), myocardial infarction (Nϭ35), or heart failure (Nϭ10). Details of the statistical analyses performed are shown in the online-only Data Supplement.
Results
Patients
The patients in the present study were at slightly higher risk of hypertensive target organ damage than the entire J-HOP Study population (Table 1) . Regarding the antihypertensive medication being taken by the 854 patients, 50.1% were taking calcium channel blockers, 6.9% were taking angiotensinconverting enzyme inhibitors, 48.6% were taking angiotensin II receptor antagonists, 15.9% were taking ␤-blockers, 7.4% were taking ␣-blockers, and 24.1% were taking thiazide diuretics. Bland-Altman plots of nighttime home and ambulatory BPs are shown in Figure 1 . Nighttime home SBP was slightly higher than nighttime ambulatory SBP (2.6Ϯ13.4 mm Hg; PϽ0.001), whereas nighttime home DBP was lower than nighttime ambulatory DBP (0.7Ϯ7.1 mm Hg; Pϭ0.007). The correlation coefficients for the relationships between the 2 systolic and diastolic measures were 0.58 and 0.68, respec- tively (ICCϭ0.57/0.68). The difference between nighttime home SBP and ambulatory SBP was significantly associated with older age, being male, a lower body mass index, a history of hypertension, antihypertensive medication use, and a history of diabetes mellitus (Table S1 , available in the online-only Data Supplement).
Comparison of Nighttime BP
Nighttime Home BP Levels and UACR
Scatter plots and regression lines of the relationships between nighttime home SBP or nighttime ambulatory SBP and log-transformed UACR are shown in Figure 2 . Nighttime home SBP displayed a stronger relationship with UACR than nighttime ambulatory BP. The relationships between clinic, awake home, nighttime home, awake ambulatory, or nighttime ambulatory BP and natural log-transformed UACR are shown in Figure S1 (available in the online-only Data Supplement). The positivity of the correlation between UACR and SBP was different for each SBP measurement. Awake home BP demonstrated a stronger relationship with UACR than awake ambulatory BP. For DBP, the relationships between log-transformed UACR and each BP measurement are shown in Figure S2 .
In Pearson correlation analysis of the linear models, the natural log-transformed UACR was found to be correlated with all of the SBP values (clinic, rϭ0.186, PϽ0.001; awake home, rϭ0.298, PϽ0.001; nighttime home, rϭ0.311, PϽ0.001; awake ambulatory, rϭ0.173, PϽ0.001; nighttime ambulatory, rϭ0.194, PϽ0.001) . There were no significant differences in the correlation coefficients for the relationships between nighttime SBP and UACR and awake SBP and UACR, in either home BP monitoring (Pϭ0.70) or ambulatory BP monitoring (Pϭ0.47); however, the correlation coefficients for the relationships between awake SBP and UACR (PϽ0.001) and nighttime SBP and UACR (PϽ0.001), obtained using home BP monitoring, were significantly greater than those obtained for the same relationships using ambulatory BP monitoring.
With regard to DBP, clinic (rϭ0.103; Pϭ0.003), awake home (rϭ0.079; Pϭ0.021), and nighttime home (rϭ0.141; PϽ0.001) DBPs were found to be associated with logtransformed UACR, but awake ambulatory (rϭ0.026; Pϭ0.449) and nighttime ambulatory (rϭ0.054; Pϭ0.118) DBPs were not. In home BP monitoring, the correlation coefficient for the relationship between UACR and nighttime DBP was significantly greater than that for the relationship between UACR and awake DBP (Pϭ0.019), but this was not the case in ambulatory BP monitoring (Pϭ0.32). The correlation coefficients for the relationships between UACR and nighttime DBP (Pϭ0.0013) and UACR and awake DBP (Pϭ0.045) obtained by home BP monitoring were significantly greater than those for the same relationships obtained by ambulatory BP monitoring.
In multiple linear regression analysis, in which clinic, awake home, nighttime home, awake ambulatory, and nighttime ambulatory SBP were entered in a stepwise manner, nighttime home SBP (Bϭ0.018, SEϭ0.004, ␤ϭ0.204, PϽ0.001) and awake home SBP (Bϭ0.015, SEϭ0.004, ␤ϭ0.167, PϽ0.001) were found to be significantly associated with natural log-transformed UACR. In the parallel analysis of DBP, nighttime home DBP, awake ambulatory DBP, and clinic DBP were selected, but we considered that awake ambulatory DBP displayed collinearity because its regression coefficient was negative.
In a multiple linear regression model of SBP, the goodnessof-fit of the relationship between SBP and UACR was incrementally improved by adding each SBP measure to clinic SBP (and confounding factors) in the following order: awake ambulatory SBP, nighttime ambulatory SBP, awake home SBP, and nighttime home SBP (Table 3) , suggesting that nighttime home SBP is associated with UACR, as has been found for nighttime ambulatory SBP. Moreover, for DBP, only adding nighttime home DBP to clinic DBP significantly improved the goodness-of-fit. Nighttime home BP even improved the goodness-of-fit when 24-hour mean ambulatory BP was included in the model instead of awake and nighttime ambulatory BPs (Table S2 ). The results of the parallel analyses using quadratic equation models were similar to those obtained using linear models and are shown in the online-only Data Supplement (Table S3) . 
Nighttime Home BP Levels and Left Ventricular Hypertrophy
Because UACR is considered to be a surrogate marker of hypertensive target organ damage in the kidneys, we analyzed the data of the 594 patients for whom echocardiographic data were available. Scatter plots and regression lines of the relationships between nighttime home SBP or nighttime ambulatory SBP and LVMI are shown in Figure 2 . The relationships between SBP and LVMI or RWT are shown in Figures S3 and S4 .
In Pearson correlation analysis of the linear models, LVMI was found to be correlated with all of the SBP values (clinic, rϭ0.135, PϽ0.001; awake home, rϭ0.248, PϽ0.001; nighttime home, rϭ0.270, PϽ0.001; awake ambulatory, rϭ0.103, Pϭ0.012; nighttime ambulatory, rϭ0.144, PϽ0.001 ). There were no significant differences in the correlation coefficients for the relationships between nighttime SBP and LVMI and awake SBP and LVMI, in either home BP monitoring (Pϭ0.52) or ambulatory BP monitoring (Pϭ0.25); however, the correlation coefficients for the relationships between awake SBP and LVMI (PϽ0.001) and nighttime SBP and LVMI (PϽ0.001), obtained using home BP monitoring, were significantly greater than those obtained for the same relationships using ambulatory BP monitoring.
In multiple linear regression analysis of the association between LVMI and SBP using a stepwise method, nighttime home SBP (Bϭ0.316, SEϭ0.084, ␤ϭ0.189, PϽ0.001) and awake home SBP (Bϭ0.225, SEϭ0.086, ␤ϭ0.131, Pϭ0.009) were found to have more significant associations with LVMI than clinic, awake ambulatory, and nighttime ambulatory SBP. In addition, the goodness-of-fit of the association between SBP and LVMI was incrementally improved by adding awake home SBP and nighttime home SBP to awake ambulatory and nighttime ambulatory SBPs (Table 3 ).
In the parallel stepwise regression analysis of the relationship between RWT and SBP including awake and nighttime ambulatory SBP, awake and nighttime home SBP, and clinic SBP, nighttime home SBP (Bϭ0.001, ␤ϭ0.121, Pϭ0.019) and awake home SBP (Bϭ0.001, ␤ϭ0.101, Pϭ0.049) were found to be significantly associated with RWT. However, the goodness-of-fit of the relationship between SBP and RWT was only improved by adding nighttime ambulatory SBP to the model (Table 3) .
With regard to DBP, in comparison with clinic DBP, none of awake ambulatory, nighttime ambulatory, awake home, or nighttime home DBPs improved their association with LVMI or RWT. The results of the parallel analyses using quadratic equation models were similar to those obtained using linear models and are shown in the online-only Data Supplement (Table S2) .
Discussion
In the present study, nighttime home SBP was found to be slightly higher than asleep ambulatory SBP (difference, 2.6 mm Hg), but Bland-Altman plots did not reveal a systematic difference between nighttime home and ambulatory SBPs. All of the SBP measures were found to be associated with log-transformed UACR, but nighttime home SBP displayed a stronger relationship with UACR than nighttime ambulatory SBP. Adding nighttime home SBP to awake home SBP and nighttime ambulatory SBP improved the goodness-of-fit of the association between SBP and UACR. Similar findings were observed for SBP when LVMI was used as the dependent variable. In terms of DBP, similar findings were also observed for the association between nighttime home DBP and UACR, but none of the DBP measures displayed significantly stronger associations with left ventricular hypertrophy compared with the other DBP measures. This is the first study to show that nighttime SBP measured using a home BP monitor is significantly associated with hypertensive target organ damage, as has been found for conventional (awake) home SBP and nighttime ambulatory SBP.
In the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study, which was performed in the general Italian population, Sega et al 6 reported that adding (awake) home BP measurement to ambulatory BP (and vice versa) progressively improved the ability of BP to predict future cardiovascular events, and our study supports their results; however, the PAMELA study did not obtain any nighttime home BP data, and in the present study, nighttime home SBP was more significantly associated with hypertensive target organ damage than nighttime ambulatory SBP. The results of this study support the notion that nighttime home BP monitoring can be beneficial for the estimation of hypertensive target organ damage in outpatients with cardiovascular risk factors.
There was a small but consistent difference between the nighttime SBP values obtained with home and ambulatory BP monitoring; however, the reason was not clear. The difference in nighttime SBP could not be explained by the use of different BP devices, because no systematic difference between these 2 SBP measures was found in Bland-Altman plots. In addition, in a previous study in which nighttime home SBP was measured at 1-hour intervals Յ6 times per night, the difference between nighttime home SBP assessed by Omron 5041 monitor and nighttime ambulatory SBP assessed by A&D TM-2025 monitor was not statistically significant (1.9 mm Hg; Pϭ0.220) . 19 In the current study, there might be a greater number of nighttime home SBP readings that were taken on awakening and in bed. In home BP monitoring, the patients had to be in bed between 2:00 and 4:00 AM to get nighttime BP readings; however, in ambulatory BP monitoring, nighttime BP was defined afterward following their diaries. The older patients displayed the greater differences between their nighttime home and nighttime ambulatory SBP. In a previous study, it was found that age was an important contributor to higher awake home SBP levels than ambulatory SBP or clinic SBP among untreated subjects. 20 The difference in nighttime home and ambulatory SBPs was associated with cardiovascular risk factors (ie, being male, the presence of hypertension, antihypertensive medication use, and the presence of diabetes mellitus), and this was probably attributable to the fact that nighttime home SBP was more strongly associated with hypertensive target organ damage than nighttime ambulatory SBP. Our finding that the relationship between nighttime home SBP and hypertensive target organ damage displayed stronger positivity than the relationship between nighttime ambulatory SBP and hypertensive target organ damage (Figure 2 ) cannot be explained by variations in physical activity because both nighttime home and ambulatory BP were measured in the same sleeping position. Nighttime home BP readings were taken on multiple days; however, the number of nighttime BP readings taken each day was higher for the ambulatory BP monitoring method than the home BP monitoring method, suggesting that measuring nighttime BP on multiple days produces results that are more significantly associated with hypertensive target organ damage than taking numerous BP readings on a single day. This was also supported by the results for awake BP; that is, awake home SBP was more significantly associated with hypertensive target organ damage than awake ambulatory SBP (the opposite relationship to that found in the PAMELA study). In the PAMELA study, awake home BP readings were taken once each in the morning and evening on a single day (2 readings), whereas 6 awake home BP readings per day were taken for 14 days in the present study (84 readings). The differences in the numbers of home BP readings taken might have been responsible for the discrepancies between the results of the 2 studies.
On the other hand, in both home BP and ambulatory BP monitoring, nighttime SBP was more strongly correlated with hypertensive target organ damage than awake SBP. Nighttime SBP can be measured in relatively stable conditions with less noise. Moreover, in ambulatory BP monitoring, nighttime BP was found to be associated with cardiovascular risk factors, such as chronic kidney disease, 21 sleep apnea, 22 and a short sleep duration, 23 as well as an increased glucose level. 24 The assessment of nighttime BP using a home BP monitor could be beneficial for patients with such risk factors.
The current study had the following limitations: the ambulatory BP monitoring and home BP monitoring were performed separately, and most of the patients were taking antihypertensive medication, and diurnal BP patterns are greatly affected by the administration of antihypertensive drugs. As a result, we found that nondipping status, a well-known risk factor for hypertensive target organ damage, 25, 26 was not associated with hypertensive target organ damage in either the home or ambulatory BP monitoring protocols (data not shown). Also, there were differences in the pharmacodynamic effects of antihypertensive drugs between awake BP and nighttime BP. However, the difference in nighttime BP between the values obtained by home and ambulatory BP monitoring could not explained by such pharmacodynamic effects, because these 2 BP measures were taken at a similar time of day. In consideration of these limitations, we need to evaluate whether the results of this article can be applied to subjects in the general population who are not taking antihypertensive medication. However, we aimed to perform this study in real clinical conditions among patients who had cardiovascular risk factors.
Perspectives
Nighttime BP assessed using a home BP monitor is comparable to that assessed using an ambulatory BP monitor. Nighttime home SBP is associated with hypertensive target organ damage, as has been found for clinic, awake ambulatory, nighttime ambulatory, and awake home SBP. The relationship between nighttime home SBP and hypertensive target organ damage was stronger than that between nighttime ambulatory SBP and hypertensive target organ damage in outpatients with cardiovascular risk factors. Measuring nighttime home SBP in addition to other SBP measures improves the association between SBP and hypertensive target organ damage. These results suggest that home BP monitors that are equipped with a timer function for taking nighttime BP readings and a memory for storing the results are beneficial for estimating hypertensive target organ damage in patients with cardiovascular risk factors. In the follow-up study, we would like to evaluate whether nighttime home BP can predict cardiovascular events in the future.
Novelty and Significance
What Is New?
• This is the first study to show that nighttime SBP measured using a home BP monitor is significantly associated with hypertensive target organ damage.
What Is Relevant?
• Home BP monitors that are equipped with a timer function for taking nighttime BP readings and a memory for storing the results may be beneficial for estimating hypertensive target organ damage.
Summary
The relationship between nighttime home SBP and hypertensive target organ damage was stronger than that between nighttime ambulatory SBP and hypertensive target organ damage in outpatients with cardiovascular risk factors. Measuring nighttime home SBP in addition to other SBP measures improves the association between SBP and hypertensive target organ damage. Sleep apnea syndrome was defined as an apnea-hypopnea index of >15 events/hour, as measured by overnight sleep polysomnography.
Echocardiography
Echocardiography was performed at each participating institute. Two-dimensional M-mode or B-mode images were obtained using an ultrasound machine according to the guidelines of the American Society of Echocardiology.
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The left ventricular mass (LVM) was obtained using the formula validated by the American Society of Echocardiology: LVM=0.8 3))+ 0.6 g, where IVSTD is the diastolic interventricular septal diameter, LVIDD is the diastolic LV dimension, and PWTD is the diastolic posterior wall diameter. The LVM index (LVMI) was calculated as LV mass / body surface area. Relative wall thickness (RWT) was calculated using the formula (IVSd + PWd) / (LVDd), where IVSd is the interventricular septum thickness at the end of diastole, PWd is the posterior wall thickness at the end of diastole, and LVDd is the LV internal dimension at the end of diastole.
Statistical analysis
Data are shown as mean+standard deviation (S.D.) values (continuous variables) or percentages (categorical variables). The UACR data had a skewed distribution and so were analyzed after being subjected to natural logarithmic transformation. The relationships between markers of hypertensive target organ damage (i.e., UACR, LVMI, and RWT) and BP were plotted in linear regression lines for clinic, awake home, nighttime home, awake ambulatory, and nighttime ambulatory BP. The relationships between hypertensive target organ damage and each BP value were also evaluated using Pearson's correlation coefficients (in the linear models) for continuous variables. The relationships between categorical variables were tested using Spearman's correlation coefficients. Intra-class correlations were examined using a strict parallel method.
The differences between the correlation coefficients were assessed using the formula created by Cohen et al. 3 To assess the independent predictive utility of the different BP measurements, multiple regression models were produced using a stepwise method. Separate analyses were performed for systolic BP (SBP) and diastolic (DBP).
Variance inflation factors were calculated to examine the possible existence of substantial multicollinearity among the BP measurements, and values of more than 3.0 were considered to indicate collinearity. In addition, the improvement of the goodness of fit achieved by incrementally adding BP measurements was computed using forced entry multiple regression analysis, (in both the linear and quadratic equation models) with age, sex, body mass index, antihypertensive medication use, the presence of hyperlipidemia, the presence of diabetes, and the presence of chronic renal damage included as covariates.
The computer software package SPSS 18.0 (SPSS Inc., Chicago, Illinois, USA) was used for all analyses. Values of p<0.05 were considered statistically significant.
Results
Predictors of the difference between nighttime home SBP and ambulatory SBP
The difference between nighttime home SBP and ambulatory SBP was significantly related to older age (r=0.212, p<0.001), being male (r=0.139, p<0.001), a lower body mass index (r=-0.163, p<0.001), regular alcohol consumption (r=0.104, p=0.002), antihypertensive medication use (r=0.093, p=0.007), and the presence of diabetes (r=0.012, p=0.003). The factors that were found to be associated with the difference between nighttime home SBP and ambulatory SBP in the multiple linear regression analysis are shown in Supplemental Table S1 .
Multiple linear regression analysis of hypertensive target organ damage
In a multiple linear regression model of BP, the goodness of fit of the relationship between SBP and UACR was incrementally improved by adding nighttime BP to 24hr ambulatory BP (Table S2) . 
